Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Metoprolol for Anxiety Treatment

Introduction to Metoprolol

  • The American Heart Association recommends metoprolol for treating performance anxiety and anxiety disorders, but it is not recommended as a first-line treatment for generalized anxiety disorder or panic disorder 1, 2

Mechanism of Action and Indications

  • Beta-blockers like metoprolol work by blocking the peripheral effects of adrenaline, reducing physical symptoms of anxiety such as rapid heart rate, tremors, and nervousness 3
  • Metoprolol is specifically indicated for performance anxiety and anxiety disorders as listed in clinical guidelines 1, 4
  • As a beta-1 selective agent, metoprolol has fewer respiratory side effects compared to non-selective beta-blockers, making it more suitable for patients with respiratory concerns 4

Clinical Efficacy

  • Beta-blockers are most effective for anxiety presentations with prominent physical symptoms, particularly those with cardiovascular manifestations 2
  • For performance anxiety (stage fright), metoprolol can effectively reduce physical symptoms that interfere with performance 3

Limitations and Considerations

  • The American Psychiatric Association notes that SSRIs and SNRIs remain the first-line pharmacological treatments for most anxiety disorders with stronger evidence for efficacy 2

Precautions and Contraindications

  • Metoprolol should be used cautiously in patients with diabetes as it may mask symptoms of hypoglycemia 1, 3
  • It should be avoided in patients with severe conduction abnormalities or sinus node dysfunction 5
  • Metoprolol is generally considered safe in pregnancy compared to other beta-blockers 1
  • Patients should not abruptly discontinue metoprolol after regular use due to risk of rebound symptoms 3

Patient Selection

  • Best candidates for metoprolol therapy include patients with performance anxiety or specific social phobias 2, 3
  • Metoprolol should be avoided in patients with severe bronchospastic pulmonary disease 5
  • Metoprolol should be avoided in patients with acute decompensated heart failure 5